<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Pharma — April 2024]]></title><description><![CDATA[<p dir="auto">After A 30% Fall In A Year Is Pfizer Stock A Better Pick Over Merck? <a href="https://www.proinvestor.com/investornyt/1139724/after-a-30-fall-in-a-year-is-pfizer-stock-a-better-pick-over-merck" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1139724/after-a-30-fall-in-a-year-is-pfizer-stock-a-better-pick-over-merck</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400885/pharma-april-2024</link><generator>RSS for Node</generator><lastBuildDate>Sun, 07 Jun 2026 07:07:12 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400885.rss" rel="self" type="application/rss+xml"/><pubDate>Wed, 03 Apr 2024 03:03:19 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Pharma — April 2024 on Tue, 30 Apr 2024 03:12:59 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038064</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038064</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Tue, 30 Apr 2024 03:12:59 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Mon, 29 Apr 2024 03:36:56 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038065</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038065</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Mon, 29 Apr 2024 03:36:56 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Fri, 26 Apr 2024 03:40:22 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038067</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038067</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Fri, 26 Apr 2024 03:40:22 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Fri, 26 Apr 2024 02:22:04 GMT]]></title><description><![CDATA[<p dir="auto">Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript <a href="https://www.proinvestor.com/investornyt/1150661/gilead-sciences-gild-q1-2024-earnings-call-transcript" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1150661/gilead-sciences-gild-q1-2024-earnings-call-transcript</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038066</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038066</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 26 Apr 2024 02:22:04 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Thu, 25 Apr 2024 10:43:57 GMT]]></title><description><![CDATA[<p dir="auto">Astrazeneca stiger efter høj efterspørgsel på kræftmidler i første kvartal <a href="https://www.proinvestor.com/investornyt/1150060/astrazeneca-stiger-efter-hoj-eftersporgsel-pa-kraeftmidler-i-forste-kvartal" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1150060/astrazeneca-stiger-efter-hoj-eftersporgsel-pa-kraeftmidler-i-forste-kvartal</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038060</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038060</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 25 Apr 2024 10:43:57 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Thu, 25 Apr 2024 02:07:31 GMT]]></title><description><![CDATA[<p dir="auto">Will Higher Keytruda Sales Drive Merck's Q1 <a href="https://www.proinvestor.com/investornyt/1150001/will-higher-keytruda-sales-drive-mercks-q1" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1150001/will-higher-keytruda-sales-drive-mercks-q1</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038058</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038058</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 25 Apr 2024 02:07:31 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Wed, 24 Apr 2024 04:01:01 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038057</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038057</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Wed, 24 Apr 2024 04:01:01 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Wed, 24 Apr 2024 03:22:00 GMT]]></title><description><![CDATA[<p dir="auto">Hanmi, Merck Collaborate To Evaluate BH3120 + Keytruda Combination In Metastatic Solid Tumors <a href="https://www.proinvestor.com/investornyt/1149381/hanmi-merck-collaborate-to-evaluate-bh3120-keytruda-combination-in-metastatic-solid-tumors" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1149381/hanmi-merck-collaborate-to-evaluate-bh3120-keytruda-combination-in-metastatic-solid-tumors</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038062</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038062</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 24 Apr 2024 03:22:00 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Wed, 24 Apr 2024 03:04:09 GMT]]></title><description><![CDATA[<p dir="auto">ALK spås fortsat bedring i det europæiske tabletsalg af Jefferies <a href="https://www.proinvestor.com/investornyt/1149400/alk-spas-fortsat-bedring-i-det-europaeiske-tabletsalg-af-jefferies" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1149400/alk-spas-fortsat-bedring-i-det-europaeiske-tabletsalg-af-jefferies</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038063</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038063</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 24 Apr 2024 03:04:09 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Wed, 24 Apr 2024 02:16:38 GMT]]></title><description><![CDATA[<p dir="auto">FDA Approves Novartis' Lutathera For Pediatric Gastroenteropancreatic Neuroendocrine Tumors <a href="https://www.proinvestor.com/investornyt/1149390/fda-approves-novartis-lutathera-for-pediatric-gastroenteropancreatic-neuroendocrine-tumors" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1149390/fda-approves-novartis-lutathera-for-pediatric-gastroenteropancreatic-neuroendocrine-tumors</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038054</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038054</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 24 Apr 2024 02:16:38 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Tue, 23 Apr 2024 04:43:31 GMT]]></title><description><![CDATA[<p dir="auto">Novartis Q1 Profit Rises, Tops Estimates; Lifts FY24 View; Proposes Giovanni Caforio As New Chair <a href="https://www.proinvestor.com/investornyt/1148848/novartis-q1-profit-rises-tops-estimates-lifts-fy24-view-proposes-giovanni-caforio-as-new-chair" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1148848/novartis-q1-profit-rises-tops-estimates-lifts-fy24-view-proposes-giovanni-caforio-as-new-chair</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038061</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038061</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 23 Apr 2024 04:43:31 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Tue, 23 Apr 2024 04:43:06 GMT]]></title><description><![CDATA[<p dir="auto">Sanofi: Rilzabrutinib LUNA 3 Phase 3 Study Meets Primary Endpoint In Immune Thrombocytopenia <a href="https://www.proinvestor.com/investornyt/1148849/sanofi-rilzabrutinib-luna-3-phase-3-study-meets-primary-endpoint-in-immune-thrombocytopenia" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1148849/sanofi-rilzabrutinib-luna-3-phase-3-study-meets-primary-endpoint-in-immune-thrombocytopenia</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038059</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038059</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 23 Apr 2024 04:43:06 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Tue, 23 Apr 2024 04:42:39 GMT]]></title><description><![CDATA[<p dir="auto">Vertex Pharma Obtains Exclusive License To TreeFrog's Cell Manufacturing Technology, C-Stem <a href="https://www.proinvestor.com/investornyt/1148845/vertex-pharma-obtains-exclusive-license-to-treefrogs-cell-manufacturing-technology-c-stem" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1148845/vertex-pharma-obtains-exclusive-license-to-treefrogs-cell-manufacturing-technology-c-stem</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038056</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038056</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 23 Apr 2024 04:42:39 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Tue, 23 Apr 2024 03:19:48 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038050</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038050</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Tue, 23 Apr 2024 03:19:48 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Mon, 22 Apr 2024 03:59:35 GMT]]></title><description><![CDATA[<p dir="auto">What's Next For Johnson &amp; Johnson Stock After Beating Q1 Earnings? <a href="https://www.proinvestor.com/investornyt/1148302/whats-next-for-johnson-amp-johnson-stock-after-beating-q1-earnings" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1148302/whats-next-for-johnson-amp-johnson-stock-after-beating-q1-earnings</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038051</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038051</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 22 Apr 2024 03:59:35 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Mon, 22 Apr 2024 03:58:51 GMT]]></title><description><![CDATA[<p dir="auto">Sandoz : Pyzchiva Approved In Europe For Gastroenterology, Dermatology, And Rheumatology Treatments <a href="https://www.proinvestor.com/investornyt/1148295/sandoz-pyzchiva-approved-in-europe-for-gastroenterology-dermatology-and-rheumatology-treatments" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1148295/sandoz-pyzchiva-approved-in-europe-for-gastroenterology-dermatology-and-rheumatology-treatments</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038049</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038049</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 22 Apr 2024 03:58:51 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Mon, 22 Apr 2024 03:22:20 GMT]]></title><description><![CDATA[<h2>Dagens aktie er Amgen Inc.</h2>
<p dir="auto">Amgen Inc. udvikler og fremstiller bioteknologi-baserede lægemidler og har fokus på områder med store udækkede medicinske behov.<br />
Pioner inden for videnskaben om at bruge levende celler til at fremstille biologisk medicin. <a href="https://www.proinvestor.com/boards/119995/" rel="nofollow ugc">https://www.proinvestor.com/boards/119995/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038046</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038046</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Mon, 22 Apr 2024 03:22:20 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Wed, 17 Apr 2024 02:00:17 GMT]]></title><description><![CDATA[<p dir="auto">Alvotech And Teva : FDA Approves Selarsdi Injection For Psoriasis And Psoriatic Arthritishttps://www.proinvestor.com/investornyt/1145923/alvotech-and-teva-fda-approves-selarsdi-injection-for-psoriasis-and-psoriatic-arthritis</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038053</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038053</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 17 Apr 2024 02:00:17 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Tue, 16 Apr 2024 03:24:13 GMT]]></title><description><![CDATA[<p dir="auto">After Nearly A 20% Rise In Six Months Will Abbott Stock See Higher Levels Post Q1? <a href="https://www.proinvestor.com/investornyt/1145276/after-nearly-a-20-rise-in-six-months-will-abbott-stock-see-higher-levels-post-q1" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1145276/after-nearly-a-20-rise-in-six-months-will-abbott-stock-see-higher-levels-post-q1</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038047</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038047</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 16 Apr 2024 03:24:13 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Tue, 16 Apr 2024 02:04:22 GMT]]></title><description><![CDATA[<p dir="auto">Novartis' Fabhalta Demonstrates Significant Proteinuria Reduction In IgA Nephropathy Patients <a href="https://www.proinvestor.com/investornyt/1145265/novartis-fabhalta-demonstrates-significant-proteinuria-reduction-in-iga-nephropathy-patients" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1145265/novartis-fabhalta-demonstrates-significant-proteinuria-reduction-in-iga-nephropathy-patients</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038045</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038045</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Tue, 16 Apr 2024 02:04:22 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Mon, 15 Apr 2024 12:13:20 GMT]]></title><description><![CDATA[<p dir="auto">TEVA det forventede raket- og droneangreb har kostet lidt på bundlinjen, men generel stiger TEVA stødt og rolig. Mon ikke det igen går fremad når Israel og Iran har fundet ud af at nok er nok.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038044</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038044</guid><dc:creator><![CDATA[Hyst]]></dc:creator><pubDate>Mon, 15 Apr 2024 12:13:20 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Wed, 10 Apr 2024 04:01:16 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038052</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038052</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Wed, 10 Apr 2024 04:01:16 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Tue, 09 Apr 2024 06:07:20 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck: Citi ser begrænset potentiale i behandling af PTSD <a href="https://www.proinvestor.com/investornyt/1142217/lundbeck-citi-ser-begraenset-potentiale-i-behandling-af-ptsd" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1142217/lundbeck-citi-ser-begraenset-potentiale-i-behandling-af-ptsd</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038055</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038055</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 09 Apr 2024 06:07:20 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — April 2024 on Tue, 09 Apr 2024 04:27:59 GMT]]></title><description><![CDATA[<p dir="auto">Is Johnson &amp; Johnson Stock A Better Pick Over AbbVie? <a href="https://www.proinvestor.com/investornyt/1142202/is-johnson-amp-johnson-stock-a-better-pick-over-abbvie" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1142202/is-johnson-amp-johnson-stock-a-better-pick-over-abbvie</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038043</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038043</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 09 Apr 2024 04:27:59 GMT</pubDate></item></channel></rss>